Decheng Capital Management III (Cayman), LLC
Q3 2023 13F Holdings
- Locationgrand cayman, E9
- Num holdings
26
- Value ($000)
$299,635
- Date Filed12/12/2023
- Form typerestatement
- CIK0001747821
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2023 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Alpine Immune Sciences, Inc. | COM | 02083G100 | $76.81M | 26 % | 6,708,288 | ||
Zentalis Pharmaceuticals Inc. | COM | 98943L107 | $42.12M | 14 % | 2,099,583 | ||
Aura Biosciences, Inc. | COM | 05153U107 | $18.24M | 6 % | 1,163,123 | ||
ROIVANT SCIENCES LTD | COM | G76279101 | $17.05M | 6 % | 1,459,700 | ||
ACELYRIN INC(NSM) | COM | 00445A100 | $15.75M | 5 % | 1,548,317 | ||
Arcus Biosciences, Inc | COM | 03969F109 | $15.61M | 5 % | 869,790 | ||
10x Genomics, Inc. | CL A COM | 88025U109 | $14.83M | 5 % | 359,554 | ||
Argenx SE | SHS | 04016X101 | $13.48M | 5 % | 27,429 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | $12.22M | 4 % | 1,463,872 | ||
Illumnia, Inc. | COM | 452327109 | $11.1M | 4 % | 80,859 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100